Drug checking results
Current warnings and particularities
6 August 2026
Warning! Ecstasy containing para-methoxymethamphetamine
Between the end of July and the beginning of August, we ingested three tablets sold as ecstasy Para-methoxymethamphetamine (PMMA) identified. These tablets are currently in circulation in Vienna and, apart from minor differences, look similar to one another.
We strongly advise against taking these tablets!
Further information here:
German: checkit!_Warnings_2026_PMMA
English: checkit!_Warnings_2026_PMMA_eng
31 July 2026
Current warnings, calendar week 31 – 2026
Between mid- and late July 2026, we tested a number of substances of particular concern to public health as part of our in-person drug-checking service. Several tablets sold as ecstasy contained ingredients other than the expected MDMA. One tablet contained PMMAanother N-Ethylpentedron and another tablet contained, instead of MDMA, a unknown substance. In a sample submitted as cannabis, the synthetic cannabinoids MDMB-INACA, ADB-4en-PINACA, MDMB-4en-PINACA, 5F-MDMB-PINACA identified. A sample submitted as cocaine contained only Procaine. Furthermore, cathinone was detected in both a sample submitted as 3-MMC and one submitted as 4-MMC N-Ethylpentedron identified. A substance sold as ‘Tusibi – pink Cocaine’ contained, in addition to MDMA, Ketamine, Caffeine and 2C-B also a unknown substance.
Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings, calendar week 31 – 2026
30 July 2026
Warning! Ecstasy containing para-methoxymethamphetamine (PMMA)
Warning! Fake ecstasy containing PMMA and NEP
Over the last few days, here at checkit! we have found unexpected ingredients in ecstasy pills. These included the substances: PMMA and NEP. The pills were bought in Vienna.
Para-methoxymethamphetamine (PMMA) has stimulant and empathogenic effects similar to those of MDMA. Unlike MDMA, however, even small doses can place a significant strain on the cardiovascular system, causing a sharp and rapid rise in blood pressure and body temperature, as well as severe muscle spasms. The delayed onset of PMMA’s effects can lead to people taking more. This can result in life-threatening overdoses.
The consumption of N-ethylpentedrone (NEP) can lead to palpitations, arrhythmia, high blood pressure or even physical restlessness and overheating of the body.
We strongly advise against the consumption of these pills.
Further information here:
15 July 2026
Current warnings for calendar week 29 – 2026
In early/mid-July 2026, we tested a range of substances of particular concern to public health. In a sample submitted for analysis as MDMA, the following were found alongside MDMA: 2-MMC detected; in another MDMA sample, a mixture of Ketamine and 2-MMC. The majority of samples submitted for analysis as 2-MMC, 3-MMC or 4-MMC (mephedrone) did not contain the expected cathinone, but rather one or more other cathinones, including N-Ethylpentedron and 4-CMC.
Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings for calendar week 29 – 2026
2 July 2026
Current warnings for calendar week 27 – 2026
Between mid- and late June 2026, we tested a number of substances of particular concern to public health as part of our in-person drug-checking service. In addition to some ecstasy tablets containing extremely high doses, one tablet was found to contain a mixture of MDMA, 4-CMC, caffeine, 1-PEA and one unknown substance detected. A sample submitted as GHB contained only GBL. In a sample sold as MDMA, the active ingredients were 4-MMC (Mephedrone), 4-CMC and 4-BEC identified.
Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings for calendar week 27 – 2026
19 June 2026
Current warnings for calendar week 25 – 2026
In early June 2026, we tested a number of substances of particular concern to public health. In two samples submitted for analysis as mephedrone (4-MMC), the following were also found: 4-BEC or 4-MEC was detected. Furthermore, in several samples sold as 3-MMC 4-CMC and/or N-ethylpentedrone (NEP) found. One sample each, labelled as LSD and MDMA, contained instead a unknown substance. Alongside a few very high doses of MDMA In addition to the expected MDMA, several ecstasy tablets were also found to contain traces of Caffeine or instead Amphetamine, 3-CMC or a unknown substance determined.
Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings for calendar week 25 – 2026
[1] The as yet unidentified opioids are new synthetic opioids (e.g. Nitazene or Fentanyle).
3 June 2026
Current warnings KW 23 - 2026
In mid to late May 2026, we tested a number of substances of particular health concern. In most of the cathinones submitted for analysis, one or more other cathinones were detected than expected, including in particular 4-CMC (4-chloromethcathinone). Furthermore, in a sample submitted for analysis as fentanyl, in addition to two previously unidentified opioids[1] which is many times more effective Carfentanil detected. A tablet submitted for analysis as ecstasy showed a unknown substance .
Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings KW 23 - 2026
[1] The as yet unidentified opioids are new synthetic opioids (e.g. Nitazene or Fentanyle).
21 May 2026
Current warnings KW 21 - 2026
In early to mid-May 2026, we tested a number of substances of particular health concern during stationary and mobile drug checking. In addition to MDMA, one sample submitted as MDMA contained the active ingredient 4-CMC was found. In two tablets dispensed as 2C-B, in addition to the expected active substance, one unknown substance detected. One cocaine sample contained only Procaine.
Under the following link, all samples that have been analysed by checkit! since the last warnings and classified as high-dose, unexpected or of particular health concern are presented in detail: Current warnings KW 21 - 2026
